Grippol Plus wins Russian Nanotechnology Product Award

During an official ceremony held on 3 December 2015, NPO Petrovax Pharm was handed the Russian Nanotechnology Product Award, which confirmed the quality, effectiveness and safety of the Grippol Plus flu vaccine, as well as its status of a nanotechnology product. As of today, Grippol Plus is the first and only medicine to receive this prestigious award. 

WHO included a new Longidaze® INN into its register
MEDSI healthcare personnel to be immunised with locally produced anti-flu vaccine Grippol Plus
Russian influenza vaccine Grippol Plus localised in Belarus
Petrovax completes government contract for supply of Grippol Plus anti-flu vaccine
Petrovax Pharm President Elena Arkhangelskaya speaks at conference “What’s going on in the pharma market?”
Kyrgyz Ministry of Health purchases Petrovax Pharm's anti-flu vaccine
Petrovax Pharm at the 3rd RBC Annual Conference “The pharma business in Russia: development strategies in times of change”
Petrovax Pharm officially recognized as a Russian pneumococcal vaccine manufacturer
Show more